- PR Newswire•yesterdayPropeller Health Completes $21.5 Million Financing to Transform Respiratory Disease through Digitally-Guided Therapy
MADISON, Wis., Oct. 20, 2016 /PRNewswire/ -- Propeller Health, the leading digital solution for respiratory medicine, today announced the closing of its $21.5 million Series C financing. The funding round includes new investors 3M Ventures, S.R. One, Limited and Hikma Ventures, and existing investors Safeguard Scientifics and Social Capital. Proceeds will be used to expand Propeller's digitally-guided therapy platform and modernize the management of respiratory disease.
- Accesswire•15 days ago
ARLINGTON, VA / ACCESSWIRE / October 6, 2016 / Safeguard Scientifics (NYSE: SFE) will be presenting at this year's The MicroCap Conference on October 24-25 in Philadelphia at the Hotel Monaco, along with ...
- PR Newswire•15 days ago
KING OF PRUSSIA, Pa., Oct. 6, 2016 /PRNewswire/ -- Trice Medical announced today that it received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for mi-eye 2, a disposable needle with a fully integrated camera that enables physicians to use advanced diagnostic imaging to visualize joint injuries in their clinic. The mi-eye 2 is designed for use in diagnostic and operative arthroscopic and endoscopic procedures to provide illumination and visualization of an interior cavity of the body through either a natural or surgical opening. The mi-eye 2 also provides physicians the ability to inject or aspirate under direct visualization.
Safeguard Scientifics, Inc. (SFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||11.88 x 100|
|Ask||19.41 x 3800|
|Day's Range||12.87 - 13.05|
|52wk Range||11.40 - 18.07|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-112.35|
|Avg Vol (3m)||40,107|
|Dividend & Yield||N/A (N/A)|